Children with rare leukaemia have better-than-expected outcomes after tailored treatment

ASH 2014: Expert discussion on the latest in AML

ASH 2014: Expert discussion on the latest in CLL

Daratumumab plus standard treatment improves outcomes in relapsed, hard-to-treat multiple myeloma in phase I study

Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study

Predicting the relapse of acute myeloid leukaemia with genetic screening

The work and aims of SPECTA for better clinical trials

New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion

Early events found to trigger lung cancer twenty years before diagnosis

Cheap DIY colorectal screening kit trialled

Potential role of blood testing for microRNA profiles in paediatric cancers

Blood-based cancer screening